The drug fenbendazole for humans is often used to treat parasitic worm infections in pets like dogs, but multiple scientific journal articles have shown that it may also be useful against various harmful cancers. It appears to be able to effectively kill cancer cells, both in cell cultures and animals, as well as reactivate the tumor suppressing gene known as p53. It has also been proven to be effective in killing a variety of different types of cancerous tumors, even when combined with radiation and other established treatment methods.
The main way that fenbendazole works is by interfering with cellular microtubules. Microtubules are important for cellular growth and division, as they help to evenly separate chromosomes during the metaphase stage of cell division.
By interfering with the formation of these microtubules, fenbendazole inhibits cell division and halts the growth of tumors in animal experiments. This effect is thought to be attributed to the fact that fenbendazole interferes with the formation of mitotic spindles, which are structures that pull chromosomes together during cell division.
Similarly, it has also been demonstrated that fenbendazole is capable of causing cancer cells to die by preventing them from receiving oxygen during the apoptosis process. Apoptosis is the final stage of cell division, during which a cellular “death machine” called the apoptosome destroys cells that are no longer vital. The apoptosome is activated by a chemical signal that is released from phosphatidylserine, an important protein that is present in cell membranes.
Fenbendazole also has the ability to impede glucose absorption in cancer cells, which starves them. This is due to the fact that it interferes with the movement of a protein known as GLUT4, which normally transports insulin-fueled glucose into cells. By blocking this influx of glucose, fenbendazole prevents the cellular growth of cancerous tumors.
Although many cancer patients have reported a successful remission using fenbendazole, there isn’t sufficient evidence that the drug cures cancer. This is because there may be other contributing factors to remission such as conventional cancer treatments, which aren’t being taken into account in these anecdotal reports. Also, the cancer may have recurred in some cases.
There’s also no proof that fenbendazole prevents recurrent cancer, as it hasn’t been tested in long-term exposure studies on humans. However, there is some scientific evidence that fenbendazole can enhance the effects of chemotherapy drugs such as paclitaxel and vincristine, as well as sodium dichloroacetate (DCA). Like other benzimidazole drugs, fenbendazole displays a powerful cancer fighting potential, but it hasn’t been proven to be an effective standalone therapy. fenbendazole for humans